Drugmaker Ranbaxy halts generic Lipitor production


Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into dozens of batches of the drug that were recalled in November.

The Food and Drug Administration says Ranbaxy won’t resume manufacturing generic Lipitor, or atorvastatin, until it determines the problem’s cause and fixes it.

The problem-plagued drugmaker, a subsidiary of India’s Ranbaxy Laboratories Ltd., since last December has been operating under increased FDA scrutiny because of quality lapses at multiple factories over several years.


advertisement

The recall covered 41 batches of 10-, 20- and 40-milligram doses of atorvastatin tablets.

A Ranbaxy spokesman did not immediately respond to messages from The Associated Press Friday.

Several other companies also make generic versions of Lipitor, which was the world’s top-selling drug for years.

© 2012 The Associated Press. All rights reserved.

More articles filed under Business News

Leave a Comment

Please use the comment box below for general comments, but if you feel we have made a mistake, typo, or egregious error, let us know about it. Click here to "call us out." We're happy to listen to your concerns.